Standout Papers
Immediate Impact
41 from Science/Nature 61 standout
Citing Papers
From discoveries in ageing research to therapeutics for healthy ageing
2019 StandoutNature
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
2019 Standout
Works of Daniel Ford being referenced
Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m2) and the Currently Approved Dose (25 mg/m2) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer—PROSELICA
2017
The sequential use of abiraterone and enzalutamide in metastatic castrate resistant prostate cancer patients: Experience from seven U.K. centers.
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Daniel Ford | 397 | 438 | 146 | 1164 | 611 | 39 | 2.1k | |
| Kirsten Vang Nielsen | 218 | 835 | 184 | 322 | 805 | 62 | 1.9k | |
| B A Ponder | 159 | 734 | 72 | 1298 | 1050 | 39 | 2.7k | |
| Rosa Ana Risques | 179 | 537 | 23 | 336 | 954 | 48 | 2.1k | |
| Irmgard Irminger‐Finger | 102 | 451 | 45 | 440 | 1261 | 54 | 1.8k | |
| Zsofia Kote‐Jarai | 1264 | 648 | 60 | 1075 | 1399 | 91 | 2.9k | |
| Hanny Odijk | 90 | 440 | 81 | 356 | 2286 | 26 | 2.7k | |
| Christopher C. Oakes | 157 | 243 | 63 | 329 | 1696 | 67 | 2.5k | |
| Peter Broderick | 463 | 539 | 17 | 801 | 1760 | 50 | 2.9k | |
| Erika M. Kwon | 794 | 265 | 40 | 519 | 718 | 48 | 1.9k | |
| Lee Anderson | 330 | 825 | 51 | 1633 | 1536 | 32 | 3.1k |
All Works
Loading papers...